Skip to content
10-Q

Quarterly Report

ALX ONCOLOGY HOLDINGS INC ALXO

0001193125-26-213399

← back to feed
Filed
May 8, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 134.56M sh
Shares Diluted Q1 2026 · Mar 31, 2026 104.57M sh
Shares Diluted Q1 2026 · Mar 31, 2025 53.36M sh
Capex Q1 2026 · Mar 31, 2026 $50K
Capex Q1 2026 · Mar 31, 2025 $60K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$18.65M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$24.66M
Long Term Debt Q1 2026 · Mar 31, 2026 $3.3M
Long Term Debt Q1 2026 · Dec 31, 2025 $4.53M
Short Term Debt Q1 2026 · Mar 31, 2026 $5.22M
Short Term Debt Q1 2026 · Dec 31, 2025 $5.22M
Short Term Investments Q1 2026 · Mar 31, 2026 $108.04M
Short Term Investments Q1 2026 · Dec 31, 2025 $28.42M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $32.28M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $16.37M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $20.61M
Stockholders Equity Q1 2026 · Mar 31, 2026 $151.35M
Stockholders Equity Q1 2026 · Dec 31, 2025 $25.98M
Stockholders Equity Q1 2026 · Mar 31, 2025 $88.3M
Stockholders Equity Q1 2026 · Dec 31, 2024 $113.62M
Current Liabilities Q1 2026 · Mar 31, 2026 $20.18M
Current Liabilities Q1 2026 · Dec 31, 2025 $24.55M
Total Liabilities Q1 2026 · Mar 31, 2026 $26.98M
Total Liabilities Q1 2026 · Dec 31, 2025 $33.07M
Current Assets Q1 2026 · Mar 31, 2026 $145.56M
Current Assets Q1 2026 · Dec 31, 2025 $50.73M
Total Assets Q1 2026 · Mar 31, 2026 $178.33M
Total Assets Q1 2026 · Dec 31, 2025 $59.05M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.17
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.58
Eps Basic Q1 2026 · Mar 31, 2026 −$0.17
Eps Basic Q1 2026 · Mar 31, 2025 −$0.58
Sga Expense Q1 2026 · Mar 31, 2026 $5.36M
Sga Expense Q1 2026 · Mar 31, 2025 $7.93M
Rd Expense Q1 2026 · Mar 31, 2026 $13.61M
Rd Expense Q1 2026 · Mar 31, 2025 $23.89M
Net Income Q1 2026 · Mar 31, 2026 −$17.93M
Net Income Q1 2026 · Mar 31, 2025 −$30.75M
Operating Income Q1 2026 · Mar 31, 2026 −$18.97M
Operating Income Q1 2026 · Mar 31, 2025 −$31.82M